Previous close | 0.1914 |
Open | 0.1961 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.1900 - 0.1961 |
52-week range | 0.1900 - 4.6000 |
Volume | |
Avg. volume | 3,795 |
Market cap | 12.511M |
Beta (5Y monthly) | 2.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BURLINGTON, Ontario, November 14, 2023--Anaergia Inc. (TSX: ANRG) announces its financial results for the three- and nine-month periods ended September 30, 2023, and its related MD&A.
BURLINGTON, Ontario, November 13, 2023--Anaergia Inc. ("Anaergia" or the "Company") (TSX: ANRG) will release financial results for the third quarter of 2023 prior to market open on Tuesday, November 14, 2023.
BURLINGTON, Ontario, September 28, 2023--Anaergia Inc. ("Anaergia" or the "Company") (TSX: ANRG) today announced that its subsidiary Rhode Island Bioenergy Facility, LLC ("RIBF") has closed a US$20 million term loan ("Loan") with East West Bank, a California Corporation, to finance remaining construction and commissioning of the RIBF project in the Town of Johnston, Rhode Island, USA and working capital. This financing has a seven-year term, and bears interest on US dollar denominated drawn fund